Diagnos Inc (DGNOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 233 | 191 | 35 | 105 | 316 |
| Marketable Securities | 23 | 175 | 38 | 424 | 605 |
| Receivables | 178 | 148 | 266 | 298 | 332 |
| TOTAL | $449 | $539 | $367 | $833 | $1,287 |
| Non-Current Assets | |||||
| PPE Net | 52 | 61 | 57 | 79 | 110 |
| Investments And Advances | 0 | 0 | 0 | 8 | 5 |
| TOTAL | $52 | $61 | $57 | $87 | $115 |
| Total Assets | $502 | $600 | $424 | $920 | $1,402 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 526 | 180 | 21 | 1,273 | 1,237 |
| Accounts payable and accrued liabilities | 194 | 201 | 258 | 584 | 492 |
| TOTAL | $768 | $443 | $309 | $1,890 | $1,809 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6 | 21 | 1 | 3 | 50 |
| Other Non-Current Liabilities | 0 | 104 | 101 | 2,878 | 2,850 |
| TOTAL | $14 | $128 | $117 | $2,903 | $2,880 |
| Total Liabilities | $782 | $572 | $427 | $4,793 | $4,689 |
| Shareholders' Equity | |||||
| Common Shares | 22,942 | 22,939 | 22,240 | 18,058 | 17,605 |
| Retained earnings | -29,603 | -29,169 | -28,379 | -28,156 | -27,373 |
| Other shareholders' equity | 6,380 | 6,258 | 6,136 | 6,225 | 6,481 |
| TOTAL | $-281 | $28 | $-3 | $-3,873 | $-3,287 |
| Total Liabilities And Equity | $502 | $600 | $424 | $920 | $1,402 |